November 11, 2026 · Neuron · DOI: 10.1016/j.neuron.2026.10.013

Antisense oligonucleotide silencing rescues neurodevelopmental deficits in AMPA receptor gain-of-function mice.

Listen to this summary

This study investigates how a recurrent GRIA1 variant (p.A636T), found in individuals with autism and intellectual disability, contributes to neurodevelopmental disease. Using a knock-in mouse model, the authors show that the variant causes ASD/ID-like behaviors, progressive hippocampal dendritic atrophy and neuronal loss driven by persistent calcium-permeable AMPAR-mediated excitotoxicity. They further demonstrate that a single neonatal dose of an allele-specific antisense oligonucleotide that silences the mutant transcript prevents hippocampal pathology and rescues behavioral deficits, supporting RNA-targeted therapy for AMPAR-related disorders.

Chih-Ming Chen, Yu-Min Huang, Chih-Ching Chung, Richard C Johnson, Cheng-Ya Tsai, Yu-Han Chen, Han L Tan, Fu-Yun Hsiao, Richard L Huganir, Shu-Ling Chiu

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play